XinThera Inc. is a structure-based drug design group that applies advanced computational chemistry technologies to design breakthrough medicines for patients. They focus on promising targets in oncology and immunology. These include both emerging and well-validated targets that have proven intractable to others in the pharmaceutical and biotechnology industry.

Education

Biotechnology

XinThera

Christopher LeMasters

Jing Liu

Nathan Ihle

Robert Hoffman

Nisha Patel

Kyle Fraher

Kevin DeMent

Donavon McConn

Craig Murphy

Gene Hung

Qing Dong

Research and Development

Leadership Team

��

Teams at XinThera

Research and Development

Leadership Team

��������

Teams at XinThera

Research and Development

Leadership Team

��